LEEEF Leef Brands Inc.
Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1711141 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin42.1%
Operating margin-16.3%
Net margin-38.2%
FCF margin-23.4%
EBITDA margin-12.3%
Returns
ROE—
ROA—
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets92.5%
Debt / equity0.00x
Current ratio2.24x
Interest coverage-3.95x
Cash quality & payout
Operating cash flow / net income0.40x
Accruals ratio—
Payout ratio—
Capex / revenue8.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $8.07M | $7.27M | $9.38M | $8.32M | $8.38M | $8.69M | $9.40M |
| Cost of revenue | $4.99M | $4.86M | $4.75M | $4.53M | $5.25M | $7.20M | $7.32M |
| Gross profit | $3.08M | $2.41M | $4.62M | $3.79M | $3.13M | $1.49M | $2.07M |
| R&D expense | $4,565 | $6,281 | $2,081 | $0 | $498 | $10,570 | $8,628 |
| SG&A expense | $802,872 | $705,705 | $601,591 | $917,531 | $673,641 | $733,569 | $797,417 |
| Operating income | -$1.51M | -$1.99M | $1.28M | -$3.17M | -$135,801 | -$2.37M | -$1.91M |
| Interest expense | $244,511 | $242,195 | $316,834 | $559,087 | $635,385 | $579,387 | $592,501 |
| Pretax income | $337,954 | -$630,698 | $548,327 | -$11.01M | -$2.77M | -$2.33M | $986,889 |
| Income tax | $56,013 | $704,050 | $974,580 | $151,548 | $1.04M | $607,891 | $721,113 |
| Net income | $281,941 | -$1.33M | -$426,253 | -$11.16M | -$3.80M | -$2.93M | $265,776 |
| EBITDA | -$1.16M | -$1.64M | $1.57M | -$2.84M | $195,022 | -$2.07M | -$1.61M |
| EPS (basic) | 0.00 | -0.01 | -0.00 | — | -0.02 | -0.02 | 0.00 |
| EPS (diluted) | 0.00 | -0.01 | -0.00 | — | -0.02 | -0.02 | 0.00 |
| Weighted avg. shares (diluted) | 305.56M | 290.00M | 259.68M | — | 180.72M | 175.44M | 266.66M |
| Balance sheet | |||||||
| Cash & equivalents | $5.90M | $4.95M | $5.76M | $2.19M | — | — | — |
| Receivables | $2.99M | $2.21M | $2.63M | $1.59M | — | — | — |
| Inventory | $8.34M | $7.15M | $3.59M | $3.35M | — | — | — |
| Current assets | $19.52M | $16.37M | $13.74M | $8.15M | — | — | — |
| PP&E, net | $26.25M | $25.55M | $24.98M | $25.04M | — | — | — |
| Goodwill | $6.05M | $6.05M | — | $0 | — | — | — |
| Intangibles | $2.23M | $2.34M | $1.08M | $1.12M | — | — | — |
| Total assets | $56.07M | $52.41M | $41.85M | $36.40M | — | — | — |
| Current liabilities | $8.73M | $7.69M | $7.85M | $8.35M | — | — | — |
| Total liabilities | $51.86M | $54.45M | $47.60M | $44.67M | — | — | — |
| Shareholders' equity | $4.21M | -$2.04M | -$5.75M | -$8.27M | -$16.22M | -$13.08M | -$10.64M |
| Shares outstanding | 305.56M | 305.56M | 265.96M | 257.95M | — | — | — |
| Cash flow statement | |||||||
| Operating cash flow | -$2.74M | -$4.07M | $395,001 | $1.35M | $350,683 | -$197,176 | -$1.84M |
| Capital expenditure | $987,178 | $1.15M | $494,839 | $27,329 | $126,805 | $325,805 | $162,075 |
| Free cash flow | -$3.73M | -$5.21M | -$99,838 | $1.32M | $223,878 | -$522,981 | -$2.00M |
| Investing cash flow | -$987,178 | -$943,912 | -$494,839 | -$166,846 | -$198,119 | -$222,183 | -$162,075 |
| Financing cash flow | $4.68M | $4.20M | $3.67M | -$904,542 | $875,845 | $391,998 | $181,903 |
| Depreciation & amortization | $352,639 | $350,235 | $285,490 | $330,865 | $330,823 | $304,107 | $294,503 |
| Stock-based compensation | $649,839 | $700,153 | $489,467 | $1.25M | $350,153 | $492,423 | $591,462 |
| Dividends paid | $90,506 | — | — | — | — | — | — |
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.